Lifestyle management and intervention alongside a once-weekly semaglutide dose of 2.4 mg. can lead to improved weight loss for patients with overweight or obesity.
Read More »Relationship between Metabolites and Lipids in People with Diabetic Retinopathy
Can specific risk markers be identified for onset and early progression of diabetic retinopathy in people with type 1 diabetes?
Read More »New Weight Loss Combo
A combined pharmacological therapy showed efficacy in bodyweight reduction without lifestyle, diet, physical activity changes or surgery.
Read More »Diabetes and Its Contributions to Early COVID-19 Outcomes
Patients with diabetes and COVID-19 were more likely to die within 14 days of hospitalization than those without diabetes.
Read More »Guiding Gestational Diabetes Treatment Through Ultrasounds
A retrospective study was conducted to determine the neonatal impact of ultrasound-guided management of gestational diabetes.
Read More »FDA Approves 1st AI Insulin Pen Cap, Making Insulin Dosing Simple
The FDA cleared The Bigfoot Unity AI Diabetes Management System by Bigfoot Biomedical for T1D & T2D management in patients of 12 or older.
Read More »Once-daily Oral vs. Once-weekly Injectable Diabetes Medications
What motivates type 2 diabetes patients' preferences for either once-daily oral or once-weekly injectable medication?
Read More »Pain and its Association with Mortality
Patients experiencing pain along with their diabetic polyneuropathy are at an increased risk of vascular events and mortality.
Read More »Treating Prediabetes Prevents Functional Decline
Older adults with prediabetes or diabetes experienced faster physical functional decline and disability progression.
Read More »Antibiotic Treatment Increases Risk for Type 1 Diabetes
Both prenatal and first year of life antibiotic exposure may increase the risk for developing type 1 diabetes in childhood.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.